Apigenin enhances sorafenib anti-tumour efficacy in hepatocellular carcinoma

CONCLUSIONS: In conclusion, Apigenin could enhance the therapeutic efficacy of Sorafenib against liver cancer and may be a promising therapeutic approach for treating HCC. However, further research is imperative to gain more in-depth mechanistic insights.PMID:38394865 | DOI:10.1016/j.tranon.2024.101920

Source: Translational Oncology - February 23, 2024 Category: Cancer & Oncology Authors: Deepti Singh Mohammad Afsar Khan Dhruv Mishra Aditya Goel Mairaj Ahmed Ansari Kafil Akhtar Hifzur R Siddique Source Type: research